A 51-year-old woman with primary left atrium leiomyosarcoma treated with surgical excision and adjuvant doxorubicin and ifosfamide remained alive without recurrence after 24 months of follow-up.
Case Report (n=1)
No
Does surgery and adjuvant chemotherapy improve survival in a patient with primary left atrium leiomyosarcoma?
This case report demonstrates a 24-month recurrence-free survival in a patient with rare primary cardiac leiomyosarcoma treated with surgery and adjuvant chemotherapy.
BACKGROUND: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases. CASE PRESENTATION: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence. CONCLUSIONS: Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.
Béhi et al. (Mon,) conducted a case report in Primary cardiac leiomyosarcoma (n=1). Surgery and adjuvant chemotherapy (Doxorubicin and Ifosfamide) was evaluated on Survival without recurrence. A 51-year-old woman with primary left atrium leiomyosarcoma treated with surgical excision and adjuvant doxorubicin and ifosfamide remained alive without recurrence after 24 months of follow-up.